Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ruud Dobber
Pharma
AZ's Dobber talks SGTL2, GLP-1 clash in heart failure
AstraZeneca's biopharma chief Ruud Dobber said doesn't see Novo's Wegovy as a threat to Farxiga in a potential clash in heart failure.
Angus Liu
Aug 29, 2023 1:30pm
AstraZeneca still plans to seek U.S. approval of its COVID shot
Apr 21, 2021 2:20pm
'Too speculative' to say when AZ will profit off COVID vax: exec
Jan 13, 2021 9:10am
AZ rejigs executive ranks around oncology, biopharma
Jan 7, 2019 11:54am
AZ's benralizumab cuts steroid use in severe asthma
May 22, 2017 2:30pm
